Table 1.
Demographic data and ocular parameters. Absolute and relative numbers, means and standard deviation, and median with interquartile range
| No. of eyes/patients | 157/157 |
|---|---|
| Eyes (right/left¸ No./%) | 78/79 (50%/50%) |
| Age (years) | 68.2 ± 11.1 |
| Gender (female/male; No./%) | 88/69 (56%/44%) |
| BCVA (logMAR) | 0.185 ± 0.245 |
| Pseudophacic (No./%) | 50 (31.8%) |
| CCT in µm | 539.4 ± 34.8 |
| HPG/NPG (No./%) | 115/42 (73.2%/26.8%) |
| MD in dB | -7.5 (IQR: -15.0…-4.0) |
| MD > − 6 dB | 63 (40%) |
| − 12 dB < MD < − 6 dB | 37 (24%) |
| MD < − 12 dB | 57 (36%) |
| PSD in dB | 6.8 (IQR: 2.6…10.7) |
| Preoperative mdIOP (mmHg) | 15.1 ± 2.6 |
| Preoperative diurnal fluctuations > 5 mmHg (No.) | 94 (59,9%) |
| Preoperative nocturnal peak IOP > 3 mmHg (No.) | 51 (32.5%) |
| IOP at time of diagnosis (mmHg) | 25.7 ± 7.1 |
| Known duration of disease (years) | 11.8 ± 8.1 |
| Number of medications | 2.9 ± 0.9 |
| Substances (No. / %) |
PGA: 143 (91.1%) β-Bl: 121 (77.1%) α-Ag: 59 (37.6%) CAI: 100 (63.7%) pilocarpin: 27 (17.2%) |
| SLT parameters: | |
|
Spots (No.) Laser Energy (mJ) |
97 ± 9 0.8 ± 0.1 |
No., number; BCVA, best corrected visual acuity; CCT, central corneal thickness; HPG, high pressure glaucoma; NPG, normal pressure glaucoma; MD, mean deviation; PSD, pattern standard deviation; IQR, interquartile range; mdIOP, mean diurnal intraocular pressure; PGA, prostaglandin analogues; ß-Blocker, Betablockers; α-Ag, Alphaagonists; CAI, carboanhydrase inhibitors; mJ, millijoule